Nextbio

{{Short description|Software company}}

{{Infobox company

| name = NextBio

| logo = Nextbio.png

| logo_size = 200px

| type = Private

| foundation = California, United States (2004)

| founder = Saeid Akhtari
Ilya Kupershmidt
Mostafa Ronaghi

| location_city = Cupertino, California

| location_country = US

| area_served = Worldwide

|| key_people = Saeid Akhtari
(President & CEO)
Ilya Kupershmidt
(VP of Product Management)
Dr. Satnam Alag
(VP of Engineering)

| num_employees = 75

| homepage = [http://www.nextbio.com/ www.nextbio.com]

}}

NextBio is a privately owned software company[https://venturebeat.com/2007/02/21/nextbio-is-latest-search-engine-for-healthcare-research-community/ Venture Beat, February 2007] that provides a platform for drug companies and life science researchers to search, discover, and share knowledge across public and proprietary data. It was co-founded by Saeid Akhtari, Ilya Kupershmidt, and Mostafa Ronaghi in 2004, and based in Cupertino, California, United States.

The NextBio Platform is an ontology-based semantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease, and compound ontologies. This framework contains information from different organisms, platforms, data types. and research areas that is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data.{{Cite web |url=http://www.bio-itworld.com/issues/2006/dec-jan/nextbio/ |title=bio-itworld.com {{!}} 2007 Release: NextBio Life Science Search Engine Advances Systems Biology Approach to Research |access-date=2008-07-23 |archive-date=2008-07-26 |archive-url=https://web.archive.org/web/20080726114426/http://www.bio-itworld.com/issues/2006/dec-jan/nextbio/ |url-status=dead }}

According to the company, the enterprise version of the NextBio platform is being used in life science research and development and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and Regeneron Pharmaceuticals.[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_28/ai_n25359106 businesswire.com | 2008 Release: NextBio Announces Public Launch of Its Life Science Search Engine] This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly available data.[http://www.nextbio.com/b/corp/faq.nb#ent_howorg nextbio.com | 2008 Release: NextBio FAQ] According to the company, scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.[http://www.nextbio.com/b/corp/user.nb nextbio.com | 2008 Release: NextBio Testimonials] In October 2013, Illumina acquired NextBio.{{Cite web|url=https://www.genengnews.com/gen-news-highlights/illumina-acquires-nextbio-in-deal-joining-sequencing-big-data/81249028|title=Illumina Acquires NextBio in Deal Joining Sequencing, Big Data {{!}} GEN|website=GEN|date=28 October 2013|access-date=2018-05-10}}{{Cite news|url=https://www.genomeweb.com/sequencing/illumina-acquire-nextbio-integrate-firm-enterprise-informatics-business#.WvQLnYiFPIU|title=Illumina to Acquire NextBio, Integrate Firm into Enterprise Informatics Business|work=GenomeWeb|access-date=2018-05-10|language=en}} In 2015, the NextBio research platform was rebranded as Correlation Engine.{{Cite web |title=Correlation Engine {{!}} Curated genomic data and mining tools |url=https://www.illumina.com/products/by-type/informatics-products/connected-analytics/modules/correlation-engine.html |access-date=2024-06-13 |website=www.illumina.com}}